PaTHway
ClinicalTrials.gov NCT04701203
Research payments
$204,267
Through program year 2024, $204,267 in research payments was reported against PaTHway, across 54 payments, paid by Ascendis Pharma, Inc..
- Paid by
- Ascendis Pharma, Inc.
- ClinicalTrials.gov
- NCT04701203
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $204,267 | 54 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
8 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Howard Kenney Spokane, WA Named on 9 payments
- Mishaela Rubin New York, NY Named on 8 payments
- Dolores Shoback San Francisco, CA Named on 7 payments
- Robert Wermers Rochester, MN Named on 7 payments
- Mark Warren Greenville, NC Named on 7 payments
- Lisa Abbott Reno, NV Named on 6 payments
- Valerie Espinosa Austin, TX Named on 5 payments
- Rajesh Jain Burr Ridge, IL Named on 5 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.